Pharmacogenetic Study of Mirtazapine Response in Depressed Patients.
Phase of Trial: Phase III
Latest Information Update: 01 Feb 2016
At a glance
- Drugs Mirtazapine (Primary)
- Indications Depression
- Focus Adverse reactions; Pharmacogenomic; Therapeutic Use
- 30 Dec 2015 Planned primary completion date changed from 1 Dec 2015 to 1 Dec 2017 as reported by ClinicalTrials.gov.
- 02 Jul 2012 Planned End Date changed from 1 Mar 2012 to 1 Mar 2015 as reported by ClinicalTrials.gov.
- 08 Jan 2010 New trial record